Last reviewed · How we verify
High dose of telmisartan
High dose of telmisartan is a Small molecule drug developed by Boehringer Ingelheim. It is currently FDA-approved.
At a glance
| Generic name | High dose of telmisartan |
|---|---|
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (PHASE3)
- Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers (PHASE1)
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? (PHASE3)
- Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension (PHASE2)
- High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension (PHASE4)
- Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension (PHASE2)
- Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers (PHASE1)
- Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High dose of telmisartan CI brief — competitive landscape report
- High dose of telmisartan updates RSS · CI watch RSS
- Boehringer Ingelheim portfolio CI
Frequently asked questions about High dose of telmisartan
What is High dose of telmisartan?
High dose of telmisartan is a Small molecule drug developed by Boehringer Ingelheim.
Who makes High dose of telmisartan?
High dose of telmisartan is developed and marketed by Boehringer Ingelheim (see full Boehringer Ingelheim pipeline at /company/boehringer-ingelheim).
What development phase is High dose of telmisartan in?
High dose of telmisartan is FDA-approved (marketed).
Related
- Manufacturer: Boehringer Ingelheim — full pipeline
- Compare: High dose of telmisartan vs similar drugs
- Pricing: High dose of telmisartan cost, discount & access